US Patent 11286289 T cell receptors
Patent 11286289 was granted and assigned to Adaptimmune on March, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11286289 T cell receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
